Table of Contents

2019-2024 Global Injectable Anticoagulants Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Injectable Anticoagulants Consumption 2014-2024
  • 2.1.2 Injectable Anticoagulants Consumption CAGR by Region
• 2.2 Injectable Anticoagulants Segment by Type
  • 2.2.1 Low-molecular-weight Heparin (LMWH)
  • 2.2.2 Direct Thrombin Inhibitor (DTI)
  • 2.2.3 Other
• 2.3 Injectable Anticoagulants Consumption by Type
  • 2.3.1 Global Injectable Anticoagulants Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Injectable Anticoagulants Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Injectable Anticoagulants Sale Price by Type (2014-2019)
• 2.4 Injectable Anticoagulants Segment by Application
  • 2.4.1 VTE
  • 2.4.2 ACS/MI
  • 2.4.3 AF
  • 2.4.4 Other
• 2.5 Injectable Anticoagulants Consumption by Application
  • 2.5.1 Global Injectable Anticoagulants Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Injectable Anticoagulants Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Injectable Anticoagulants Sale Price by Application (2014-2019)

3 Global Injectable Anticoagulants by Players

• 3.1 Global Injectable Anticoagulants Sales Market Share by Players
  • 3.1.1 Global Injectable Anticoagulants Sales by Players (2017-2019)
  • 3.1.2 Global Injectable Anticoagulants Sales Market Share by Players (2017-2019)
• 3.2 Global Injectable Anticoagulants Revenue Market Share by Players
  • 3.2.1 Global Injectable Anticoagulants Revenue by Players (2017-2019)
  • 3.2.2 Global Injectable Anticoagulants Revenue Market Share by Players (2017-2019)
• 3.3 Global Injectable Anticoagulants Sale Price by Players
• 3.4 Global Injectable Anticoagulants Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Injectable Anticoagulants Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Injectable Anticoagulants Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Injectable Anticoagulants by Regions

• 4.1 Injectable Anticoagulants by Regions
  • 4.1.1 Global Injectable Anticoagulants Consumption by Regions
  • 4.1.2 Global Injectable Anticoagulants Value by Regions
• 4.2 Americas Injectable Anticoagulants Consumption Growth
• 4.3 APAC Injectable Anticoagulants Consumption Growth
• 4.4 Europe Injectable Anticoagulants Consumption Growth
• 4.5 Middle East & Africa Injectable Anticoagulants Consumption Growth

5 Americas

• 5.1 Americas Injectable Anticoagulants Consumption by Countries
  • 5.1.1 Americas Injectable Anticoagulants Consumption by Countries (2014-2019)
  • 5.1.2 Americas Injectable Anticoagulants Value by Countries (2014-2019)
• 5.2 Americas Injectable Anticoagulants Consumption by Type
• 5.3 Americas Injectable Anticoagulants Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Injectable Anticoagulants Consumption by Countries
  • 6.1.1 APAC Injectable Anticoagulants Consumption by Countries (2014-2019)
  • 6.1.2 APAC Injectable Anticoagulants Value by Countries (2014-2019)
• 6.2 APAC Injectable Anticoagulants Consumption by Type
• 6.3 APAC Injectable Anticoagulants Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Injectable Anticoagulants by Countries
  • 7.1.1 Europe Injectable Anticoagulants Consumption by Countries (2014-2019)
  • 7.1.2 Europe Injectable Anticoagulants Value by Countries (2014-2019)
• 7.2 Europe Injectable Anticoagulants Consumption by Type
• 7.3 Europe Injectable Anticoagulants Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Injectable Anticoagulants by Countries
  • 8.1.1 Middle East & Africa Injectable Anticoagulants Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Injectable Anticoagulants Value by Countries (2014-2019)
• 8.2 Middle East & Africa Injectable Anticoagulants Consumption by Type
• 8.3 Middle East & Africa Injectable Anticoagulants Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Injectable Anticoagulants Distributors
• 10.3 Injectable Anticoagulants Customer

11 Global Injectable Anticoagulants Market Forecast

• 11.1 Global Injectable Anticoagulants Consumption Forecast (2019-2024)
• 11.2 Global Injectable Anticoagulants Forecast by Regions
  • 11.2.1 Global Injectable Anticoagulants Forecast by Regions (2019-2024)
  • 11.2.2 Global Injectable Anticoagulants Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Injectable Anticoagulants Forecast by Type
• 11.8 Global Injectable Anticoagulants Forecast by Application

12 Key Players Analysis

• 12.1 Sanofi
  • 12.1.1 Company Details
  • 12.1.2 Injectable Anticoagulants Product Offered
  • 12.1.3 Sanofi Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Sanofi News
• 12.2 Genentech (Roche)
  • 12.2.1 Company Details
  • 12.2.2 Injectable Anticoagulants Product Offered
  • 12.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Genentech (Roche) News
• 12.3 Boehringer Ingelheim
  • 12.3.1 Company Details
  • 12.3.2 Injectable Anticoagulants Product Offered
  • 12.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Boehringer Ingelheim News
• 12.4 Pfizer
  • 12.4.1 Company Details
  • 12.4.2 Injectable Anticoagulants Product Offered
  • 12.4.3 Pfizer Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Pfizer News
• 12.5 The Medicines Company
  • 12.5.1 Company Details
  • 12.5.2 Injectable Anticoagulants Product Offered
  • 12.5.3 The Medicines Company Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 The Medicines Company News
• 12.6 Aspen
  • 12.6.1 Company Details
  • 12.6.2 Injectable Anticoagulants Product Offered
  • 12.6.3 Aspen Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Aspen News
• 12.7 Otsuka
  • 12.7.1 Company Details
  • 12.7.2 Injectable Anticoagulants Product Offered
  • 12.7.3 Otsuka Injectable Anticoagulants Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Otsuka News

...

13 Research Findings and Conclusion

The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).
In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in 2016 is about 55%, and the proportion is in decreasing trend from 2012 to 2016.
Injectable anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of injectable anticoagulants used to treat AF, and the revenue in 2016 is 3400 M USD.

According to this study, over the next five years the Injectable Anticoagulants market will register a 2.7% CAGR in terms of revenue, the global market size will reach US$ 6440 million by 2024, from US$ 5490 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Injectable Anticoagulants business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Anticoagulants market by product type, application, key manufacturers and key regions and countries.

This study considers the Injectable Anticoagulants value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
VTE
ACS/MI
AF
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company 
Aspen
Otsuka
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Injectable Anticoagulants consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Injectable Anticoagulants market by identifying its various subsegments.
Focuses on the key global Injectable Anticoagulants manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Injectable Anticoagulants with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Injectable Anticoagulants submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.